In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors (2013)
- Authors:
- USP affiliated authors: MORALES, ANDRESSA GOIS - IB ; OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidades: IB; FMRP
- DOI: 10.4161/cbt.25087
- Subjects: CARCINOMA; NEOPLASIAS DA BEXIGA; ANTINEOPLÁSICOS (ESTUDO IN VITRO)
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Biology and Therapy
- ISSN: 1538-4047
- Volume/Número/Paginação/Ano: v. 14, n. 7, p. 648-657, 2013
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
BRASSESCO, María Sol et al. In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors. Cancer Biology and Therapy, v. 14, n. 7, p. 648-657, 2013Tradução . . Disponível em: https://doi.org/10.4161/cbt.25087. Acesso em: 01 abr. 2026. -
APA
Brassesco, M. S., Pezuk, J. A., Morales, A. G., Oliveira, J. C. de, Roberto, G. M., Silva, G. N. da, et al. (2013). In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors. Cancer Biology and Therapy, 14( 7), 648-657. doi:10.4161/cbt.25087 -
NLM
Brassesco MS, Pezuk JA, Morales AG, Oliveira JC de, Roberto GM, Silva GN da, Oliveira HF de, Scrideli CA, Tone LG. In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors [Internet]. Cancer Biology and Therapy. 2013 ; 14( 7): 648-657.[citado 2026 abr. 01 ] Available from: https://doi.org/10.4161/cbt.25087 -
Vancouver
Brassesco MS, Pezuk JA, Morales AG, Oliveira JC de, Roberto GM, Silva GN da, Oliveira HF de, Scrideli CA, Tone LG. In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors [Internet]. Cancer Biology and Therapy. 2013 ; 14( 7): 648-657.[citado 2026 abr. 01 ] Available from: https://doi.org/10.4161/cbt.25087 - Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation
- Characterization of LGALS3 (galectin-3) as a player in DNA damage response
- Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells
- MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells
- Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro
- Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells
- Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia
- BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity
- Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells
- PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
